Summary The COVID-19 Workshop Series is a 4-part series on current pharmaceutical developments for cures and prevention and immunogenicity in the time of COVID. Experts in their fields will address independent performance evaluation of COVID tests, pandemic crisis readiness, regulatory perspectives, global supply chain, epidemiology, next generation assay approaches and immune response. As a member benefit, access to all of these informative sessions is free for all AAPS members. Opening Session – Managing an Infectious Disease Pandemic: Historic Lessons, Current and Future Approaches International Response – Testing and Analytical Approaches Regulatory Perspectives – Agency Response and Guidance Therapeutic and Preventive Approaches Epidemiology Pharmaceutical Business Continuity During a Pandemic Preparedness Policy: How to Prepare for Emerging Infectious Disease Needs and Respond with Rapid Research Development The Global Supply Chain: Vulnerabilities, Need for Transparency and Building Resilience in the Supply Chain Independent Performance Evaluation of COVID Tests – PCR-based assays Independent Performance Evaluation of COVID Tests –Serology Tests COVID 19-Regulatory Perspectives New Assay Approaches, Reagents and Future Improvement Overview of the Immune Response to SARS-CoV-2, Hyperinflammation and Cytokines Immunogenicity Considerations for Therapeutic Proteins in COVID Patients